News
ProPhase Labs Q4 EPS $(0.51) Misses $(0.26) Estimate, Sales $4.35M Miss $10.69M Estimate
15 Mar 24
Earnings, News
Earnings Scheduled For March 15, 2024
15 Mar 24
Earnings
ProPhase Labs's Earnings: A Preview
14 Mar 24
Earnings
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $11 Price Target
21 Feb 24
News, Price Target, Reiteration, Analyst Ratings
ProPhase Labs Announces Progress At Pharmaloz Manufacturing Accelerating Expansion, Improves Pricing, Boosts Profitability And Secures New Contracts
23 Jan 24
News, Contracts
Prophase Poised To Ramp Up Growth At Pharmaloz And Nebula Genomics In 2024; Company Announces The Hiring Of Long-Time Industry Veteran Jed Latkin As COO To Help Build And Manage This Growth
4 Jan 24
Biotech, News, Management, General
Press releases
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
8 Mar 24
Press Releases
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
21 Feb 24
Press Releases
Sidus Space Appoints Bill White as Chief Financial Officer
8 Feb 24
Press Releases
Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI)
8 Feb 24
Press Releases, General
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
4 Jan 24
Press Releases